Market Research Logo

Global Fallopian Tube Cancer Therapeutics Market 2019-2023

Global Fallopian Tube Cancer Therapeutics Market 2019-2023

Global Fallopian Tube Cancer Therapeutics Market: About this market

Fallopian tube cancer is a less common type of gynecologic cancer and accounts for approximately 1%-2% of all gynecologic cancer cases. Technavio’s fallopian tube cancer therapeutics market analysis considers sales from both targeted therapy and chemotherapy. Our analysis also considers the sales of fallopian tube cancer therapeutics in APAC, Europe, North America, South America, and MEA. In 2018, the targeted therapy segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as heavy research on targeted therapies, high efficacy of the same will play a significant role in the targeted therapy segment to maintain its market position. Also, our global fallopian tube cancer therapeutics market report also looks at factors such as growing attention toward women's health, an array of strong drug approvals, strategic alliance. However, difficulty in diagnosis, the strong threat from substitutes, high cost of treatment may hamper the growth of the fallopian tube cancer therapeutics industry over the forecast period.

Global Fallopian Tube Cancer Therapeutics Market: Overview

Array of strong drug approvals

One of the major growth factors of the global fallopian tube cancer therapeutics market is the increasing number of drug approvals in recent years. Various pharmaceutical vendors started conducting research on novel targeted therapies. These targeted therapies have an affinity toward inhibiting the overexpression of a specific target and increasing the immunity of the body toward cancerous cells. The market also witnesses the presence of various other targeted therapies in the late stages of the pipeline for the treatment of fallopian tube cancer. Two of the heavily researched targeted therapies for the indication are PD-1 inhibitors and PD-L1 inhibitors. The studies conducted in the early stages of clinical trials for fallopian tube cancer suggest that these drugs show a significant reduction in the tumor while providing long-term relief. Such factors will lead to the expansion of the global fallopian tube cancer therapeutics market at a CAGR of over 8% during the forecast period.

Use of nanotechnology for effective treatment

Various researchers are conducting studies on developing a nanoparticle-based drug delivery system, which could help the drug in reaching the target site without reducing its bioavailability. They increase the half-life of the drug in the circulatory system and have the ability to bypass the barriers caused by the blood tissue, specific target tissues, and cells. They increase the onset of the drug while providing a prolonged therapeutic action. These factors help nanoparticles to be an effective drug delivery for the administration of chemotherapy drugs. as it helps in overcoming drug resistance mechanisms in various tumors while enhancing the drug penetration into the tumor. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global fallopian tube cancer therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global fallopian tube cancer therapeutics market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fallopian tube cancer therapeutics manufacturers, that include AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, and Pfizer Inc.

Also, the fallopian tube cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Pipeline
    • Table Global fallopian tube cancer therapeutics market: Overview
    • Table Global fallopian tube cancer therapeutics market: Snapshot
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Targeted therapy - Market size and forecast 2018-2023
      • Table Targeted therapy - Market size and forecast 2018-2023 ($ millions)
      • Table VEGF inhibitors share in targeted therapy 2018-2023
      • Table PARP inhibitors share in targeted therapy 2018-2023
      • Table Other inhibitors share in targeted therapy 2018-2023
      • Table Targeted therapy - Year-over-year growth 2019-2023 (%)
    • Chemotherapy - Market size and forecast 2018-2023
      • Table Chemotherapy - Market size and forecast 2018-2023 ($ millions)
      • Table Chemotherapy - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Growing research on regenerative therapies
    • Advent of treatment vaccines for cancer
    • Use of nanotechnology for effective treatment
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Vendor overview
      • Table AstraZeneca Plc - Business segments
      • Table AstraZeneca Plc - Organizational developments
      • Table AstraZeneca Plc - Geographic focus
      • Table AstraZeneca Plc - Key offerings
      • Table AstraZeneca Plc - Key customers
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. - Vendor overview
      • Table Bristol-Myers Squibb Co. - Business segments
      • Table Bristol-Myers Squibb Co. - Organizational developments
      • Table Bristol-Myers Squibb Co. - Geographic focus
      • Table Bristol-Myers Squibb Co. - Key offerings
      • Table Bristol-Myers Squibb Co. - Key customers
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Vendor overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F. Hoffmann-La Roche Ltd. - Organizational developments
      • Table F. Hoffmann-La Roche Ltd. - Geographic focus
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Key customers
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Vendor overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Organizational developments
      • Table GlaxoSmithKline Plc - Geographic focus
      • Table GlaxoSmithKline Plc - Segment focus
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report